Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine

Research output: Contribution to journalReviewResearchpeer-review

  1. PACAP38 and PAC receptor blockade: a new target for headache?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cilostazol induced migraine does not respond to sumatriptan in a double blind trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Functional connectivity studies in migraine: what have we learned?

    Research output: Contribution to journalReviewResearchpeer-review

  2. Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: A 3T MRI study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Post-traumatic headache: epidemiology and pathophysiological insights

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

BACKGROUND: Pituitary adenylate cyclase-activating polypeptide (PACAP) is widely distributed in the nervous system and is involved in migraine pathophysiology. Understanding the function of the blood-brain barrier (BBB) in relation to PACAP is important to the understand the mechanisms behind PACAP-induced migraine attacks, but also to develop antimigraine drugs targeting the PACAP receptors Here, we aim to review the transport ability of PACAP across the BBB.

METHODS: We performed a systematic literature search on PubMed to identify studies reporting original data on PACAP and BBB. The search was finalized in July 2017.

RESULTS: The literature search identified 96 papers of which 11 contained relevant data. In addition, two papers were known to be relevant and were included. A total of 13 papers studies were included in the final analysis. Preclinical studies (n = 10) suggest the existence of specific PACAP transport systems across the BBB, while human PACAP studies failed to show vasodilator effect of PACAP on the cerebral arteries from the lumen (n = 3).

CONCLUSION: PACAP38 is transported over the BBB actively, while PACAP27 cross the BBB by diffusion over the membrane, but after crossing the endothelial membrane both isoforms are either rapidly degraded or efflux back from brain to blood. Thus, a direct central action of the PACAPs is unlikely. This is supported by studies showing selective PACAP effect on extra-cerebral arteries.

Original languageEnglish
JournalJournal of Headache and Pain
Volume19
Issue number1
Pages (from-to)35
ISSN1129-2369
DOIs
Publication statusPublished - 2018

    Research areas

  • Animals, Blood-Brain Barrier/metabolism, Brain/metabolism, Cerebral Arteries/metabolism, Humans, Migraine Disorders/metabolism, Pituitary Adenylate Cyclase-Activating Polypeptide/metabolism, Protein Transport/physiology, Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide/metabolism

ID: 55592424